Home » ANDA Filers in U.S. Should Follow ICH Stability Testing Guidelines
ANDA Filers in U.S. Should Follow ICH Stability Testing Guidelines
July 10, 2013
The U.S. Food and Drug Administration has adopted international recommendations for abbreviated new drug application (ANDA) stability testing, brushing aside complaints from generic drugmakers that the guidelines are heavy-handed.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor